Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

Vitamin A toxicity likely caused the patient's high calcium levels.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

For better medication adherence in benign prostatic hyperplasia treatment, tamsulosin and finasteride should be packaged together and taken at the same time.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Silver nanoparticles made from Grewia optiva leaf extract show strong antibacterial, antioxidant, and hair growth benefits.

Patients follow treatment well, but many change medicines; good information helps compliance.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Testosterone therapy increases bone density in older men with low testosterone levels.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Dutasteride effectively and safely treats male hair loss for over a year.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.